HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance.

MLA

Huang, Shih-Chiang, et al. “HER2 Testing in Paired Biopsy and Excision Specimens of Gastric Cancer: The Reliability of the Scoring System and the Clinicopathological Factors Relevant to Discordance.” Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 19, no. 1, Jan. 2016, pp. 176–82. EBSCOhost, https://doi.org/10.1007/s10120-014-0453-0.

APA

Huang, S.-C., Ng, K.-F., Lee, S.-E., Chen, K.-H., Yeh, T.-S., & Chen, T.-C. (2016). HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 19(1), 176–182. https://doi.org/10.1007/s10120-014-0453-0

Chicago

Huang, Shih-Chiang, Kwai-Fong Ng, Shang-En Lee, Kuang-Hua Chen, Ta-Sen Yeh, and Tse-Ching Chen. 2016. “HER2 Testing in Paired Biopsy and Excision Specimens of Gastric Cancer: The Reliability of the Scoring System and the Clinicopathological Factors Relevant to Discordance.” Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 19 (1): 176–82. doi:10.1007/s10120-014-0453-0.